These studies suggest that GLP-1RAs may improve liver function and insulin sensitivity, reduce liver fat and hepatic inflammation, and increase the resolution of NASH; but about the mitigation of hepatic fibrosis and prevention of liver cirrhosis are unclear. This evidence concerns the gene INS and metabolic dysfunction-associated steatohepatitis.